HB 1852 — AN ACT to amend Tennessee Code Annotated, Title 33; Title 37; Title 44; Title 47; Title 49; Title 53; Title 63 and Title 68, relative to health.
Last action — Failed for lack of motion in: Population Health Subcommittee
-
✓Introduced
-
2In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill is in committee in the House. Introduced January 20, 2026. It must pass committee before a floor vote.
Next likely step: a committee vote, then a floor vote in the House.
Odds of enactment
Low chanceBased on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
-
In Committee
Current position in the legislative process.
-
1 sponsor
1 primary, 0 co-sponsors signed on.
-
Single-party support
Sponsorship is currently within one party (1 R).
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
Summary
Health Care - As introduced, enacts the "Tennessee mRNA Pharmaceutical Sovereignty and Safety Act," which prohibits individuals, including professional providers of health care and veterinary medicine, from administering any vaccine or other injectable solution that contains an mRNA vaccine or vaccine material. - Amends TCA Title 33; Title 37; Title 44; Title 47; Title 49; Title 53; Title 63 and Title 68.
Bill Text
- Full text View text Current pdf
Action History
-
Filed for introduction
-
Introduced, Passed on First Consideration
-
Passed on Second Consideration, refer to Senate Health and Welfare Committee
-
Sponsor change.
-
Placed on Senate Health and Welfare Committee calendar for 3/11/2026
-
Action deferred in Senate Health and Welfare Committee to 3/18/2026
-
Filed for introduction
-
Intro., P1C.
-
P2C, ref. to Health Committee
-
Assigned to s/c Population Health Subcommittee
-
Placed on s/c cal Population Health Subcommittee for 3/10/2026
-
Failed for lack of motion in: Population Health Subcommittee
Sponsors
- Monty Fritts · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 132 not signed on
Sponsors (1)
- Fritts, Monty Republican
Co-sponsors (0)
None.
Not signed on (132)
132 members have not signed on to this bill.
Show all 132 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HB 1852 do?
- Health Care - As introduced, enacts the "Tennessee mRNA Pharmaceutical Sovereignty and Safety Act," which prohibits individuals, including professional providers of health care and veterinary medicine, from administering any vaccine or other injectable solution that contains an mRNA vaccine or vaccine material. - Amends TCA Title 33; Title 37; Title 44; Title 47; Title 49; Title 53; Title 63 and Title 68.
- Who sponsors HB 1852?
- HB 1852 is sponsored by Fritts, Monty (Republican).
- What is the current status of HB 1852?
- This bill is in committee in the House. Introduced January 20, 2026. It must pass committee before a floor vote.
- Where can I track HB 1852?
- Track HB 1852 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB 1852
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB 1852
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →